WHY WE

NEED YOU

3 - 9 June 2019

Last year, breast cancer became the most commonly diagnosed cancer in Australia. Its incidence is increasing – meaning far too many people will be impacted, far too often.

This year, 53 a day will be diagnosed. Over 3,000 will lose their life.

By raising funds and going pink with us this June, you’ll be taking a stand against breast cancer - and helping the National Breast Cancer Foundation fund world-class research that will detect tumours earlier, improve outcomes and ultimately - save lives.

YOU'LL BE HELPING SAVE LIVES


WOMEN WILL BE
DIAGNOSED WITH
BREAST CANCER IN
THEIR LIFETIME 


WOMEN DIE FROM
BREAST CANCER EVERY
DAY IN AUSTRALIA


MEN WILL
BE DIAGNOSED IN
THEIR LIFETIME

MAKE TOMORROW BETTER.
FUND RESEARCH TODAY.

- Dr. Tu Nyuyen-Dunmont,
NBCF-funded researcher

REGISTER

IMPACT OF YOUR FUNDRAISING

Helps fund researchers develop training tools for radiologists to improve the accuracy of breast cancer screenings

Helps fund researchers investigate how changes in the immune system can increase the risk of breast cancer

Helps fund researchers identify new non-genetic risk factors for breast cancer

Helps researchers identify other DNA defects that may contribute to the development of breast cancer

WHO YOU’RE HELPING FUND

PROFESSOR PATRICK BRENNAN
University of Sydney, NSW
IMPROVING SCREENING PRACTICES

Regular mammograms are very effective in the early detection of breast cancer. However it is estimated that 5 - 50% of cancers are currently missed during screenings.

Professor Brennan’s research aims to develop technologies and techniques that enhance the detection of breast cancer indicators, while minimising risk to the patient and reducing the number of cancers that are missed.

DR TU NGUYEN-DUNMONT
Monash University, VIC
UNDERSTANDING GENETIC LINKS

Genetic testing is the most effective way for women and their families to confirm if they have an inherited predisposition to breast cancer.

While new technology enables doctors to screen multiple genes for mutations at once, we have limited understanding of the variation observed in the genes included in these tests. As a result, it can be very frustrating for women with a family history of breast cancer who are left with no explanation for their risk and aren’t able to receive appropriate clinical management for themselves and their family.

PROFESSOR JOHN HOPPER
University of Melbourne
MEASURING BREAST CANCER RISK

While mammographic screenings aim to detect breast tumours, they also have the potential to detect breast cancer risk by accurately measuring breast tissue density. We’ve known for some time that higher breast tissue density means a higher risk of breast cancer.

Professor Hopper aims to examine how breast tissue density combined with lifestyle, medication, genetic factors and family history may produce a simple “risk prediction score” for screening women.

If individuals with the highest risk of breast cancer can be identified, they will have greater preventative options and improved long-term outcomes.

ABOUT THE NATIONAL BREAST CANCER FOUNDATION

The National Breast Cancer Foundation is the only national body that funds life-changing breast cancer research with money raised entirely by the Australian public.

Our research has helped develop better therapies, greater understanding of possible ways to stop the spread of breast cancer to other areas, and improved quality of life for patients and their families’ to read ‘Our research has helped develop better therapies, provided a greater understanding of possible ways to stop the spread of breast cancer to other areas, and improved quality of life for patients and their families’

By funding only world-class research, National Breast Cancer Foundation is working towards a goal of zero deaths from breast cancer by 2030.

Learn More